In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-18 of 18 for your search:
Drug:  soy isoflavones
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-969258, NCI-P97-0126

2.

Phase: Phase III
Type: Prevention
Status: Completed
Age: 50 to 80
Sponsor: NCI
Protocol IDs: MCC-0002, NCI-4031, NCI-P01-0195, NCT00027950

3.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Tissue collection/Repository
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CLIN-006-05S, NCT00255125

4.

Phase: Phase III
Type: Supportive care
Status: Closed
Age: 21 and over
Sponsor: NCI
Protocol IDs: CCCWFU-97405, CCCWFU 97405, WFU-97405, CCCWFU-BG05-529, NCT00354432

5.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Closed
Age: 30 to 45
Sponsor: NCI
Protocol IDs: UHM-CHS-4116, CHS 14116, NCT00513916

6.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000353197, P30CA022453, WSU-C-2418, NCT00078923

7.

Phase: Phase II
Type: Prevention
Status: Closed
Age: 30 to 42
Sponsor: NCI, Other
Protocol IDs: 03-260, UTMB GCRC #635, R01CA095545, M01RR000073, 1UL1RR029876-01, NCT00204490

8.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: CDR0000466317, CCCWFU-98203, CCCWFU-BG03-332, NCT00345813

9.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: CDR0000554969, P30CA012197, CCCWFU-85106, CCCWFU-IRB00000371, NCT00499408

10.

Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 9639, NCT00594620

11.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 50 to 80
Sponsor: Other
Protocol IDs: MCC-12835, NCI #4031, CA 81920, NCT00617617

12.

Phase: No phase specified
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCMC-CHMC-91-5-3, NCI-P97-0117, NCT00003100

13.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 45 to 80
Sponsor: NCI, Other
Protocol IDs: MCC-13004, NCI-3811, NCI-P02-0216, 0105, MCC-0105, HLMCC 0105, NCT00042731

14.

Phase: No phase specified
Type: Behavioral study, Educational/Counseling/Training, Supportive care
Status: Closed
Age: 21 and over
Sponsor: NCI
Protocol IDs: CCCWFU-98904, NCT00343434

15.

Phase: No phase specified
Type: Treatment
Status: Closed
Age: 45 and over
Sponsor: Other
Protocol IDs: PROS0022, 97408, NCT00482157

16.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 35 to 50
Sponsor: Other
Protocol IDs: R14697, 07/Q0101/10, NCT00555386

17.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention, Tissue collection/Repository
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 12052, NCT01174953

18.

Phase: No phase specified
Type: Diagnostic, Prevention, Treatment
Status: Closed
Age: 30 to 75
Sponsor: NCI, Other
Protocol IDs: 1B-10-6, NCI-2010-01847, NCT01219075
New Search